AI-powered contentSome parts of this article are powered by AI.
Share this article
Summary
UnitedHealth (UNH) fell 5.42% to $389.68 on November 17, 2026, far more than the Nasdaq Composite's 0.74% decline.
Financial media tied the drop to CRUSH, a proposed rule that would widen Medicare Advantage audits and extrapolate findings back to payment year 2018.
UnitedHealth has not sized the potential hit, according to TIKR, and comments on the proposal close January 19, 2027.
Gotrade News - In the latest UnitedHealth stock news, shares of UnitedHealth (UNH) fell 5.42% to close at $389.68 on Tuesday, November 17, 2026, a drop of $22.34 from the previous close of $412.02.
Financial media tied the slide in UnitedHealth stock to a federal proposal that would widen audits of Medicare Advantage plans and reach back to payment year 2018.
UNH Trading Data
Data
Value
Closing price
$389.68
Change
-$22.34 (-5.42%)
Previous close
$412.02
Open
$399.23
Day range
$387.14 to $399.99
Volume
8.0 million shares
30-day average volume
5.8 million shares
52-week range
$255.97 to $461.62
Market cap
$349.2 billion
Regular-session close on Tuesday, November 17, 2026, 4:00 p.m. New York time. Stock prices: Yahoo Finance, cross-checked against the closing price on Nasdaq.com. Volume and 30-day average volume: Nasdaq.com. 52-week range: Yahoo Finance daily highs and lows since November 18, 2025. Indices: Yahoo Finance daily closes for the same date. 10-year Treasury yield: U.S. Treasury daily par yield curve for the same date.
The stock opened at $399.23, well below Monday's close, and never got back to that level during the day. It traded between $387.14 and $399.99 and finished just $2.54 above the session low. Volume reached 8.0 million shares, 39.50% above the 5.8 million share average.
The decline was far steeper than the broader market. The Nasdaq Composite fell 0.74% to 24,328.38, the S&P 500 lost 1.03% to 7,340.53 and the Dow Jones Industrial Average dropped 1.64% to 50,759.42, leaving UnitedHealth 4.68 percentage points behind the Nasdaq. The US 10-year Treasury yield fell 2.0 basis points to 5.10%. Elsewhere in health care, Eli Lilly (LLY) slipped 1.13% and Novo Nordisk (NVO) fell 2.16%.
After the drop, the stock sits 15.58% below its 52-week high of $461.62 and 52.24% above its 52-week low of $255.97, with a market value of $349.2 billion.
Why UnitedHealth Stock Fell
On November 16, federal health officials proposed a rule called CRUSH, short for Comprehensive Regulations to Uncover Suspicious Healthcare, that would expand Medicare Advantage audits, according to GuruFocus.
The rule would codify risk adjustment data validation audits without a fee-for-service adjuster and extrapolate the findings starting with payment year 2018. CMS estimates the approach would recover about $9 billion per payment year on average, and comments are due January 19, 2027.
GuruFocus described extrapolation as the key change, because a coding error found in a sample can be multiplied across an entire contract. As reported by TIKR, CMS Administrator Dr. Mehmet Oz framed the rule as a way to "crush fraud, waste, and abuse," while UnitedHealth, the largest Medicare Advantage insurer, has not sized the potential hit. Managed care peers Humana and CVS Health also traded lower, GuruFocus reported.
Per 24/7 Wall St., the selling also followed a call by Sen. Elizabeth Warren to break up major health care conglomerates, in which she named UnitedHealth alongside two other vertically integrated insurers. UnitedHealth issued no press release on the day, the outlet noted.
UNH Stock Analysis: Supporting Factors and Risks
Supporting Factors
CRUSH is still a proposal: comments close January 19, 2027, and TIKR notes that the rule could still change.
UnitedHealth reported third-quarter adjusted EPS of $4.69 against a $4.15 consensus and raised its 2026 adjusted EPS outlook to at least $20.50, per 24/7 Wall St.
Risks
CMS premiums made up 44% of UnitedHealth's 2025 revenue, according to TIKR, so Medicare Advantage rules weigh heavily on its results.
Extrapolated audits reaching back to payment year 2018 leave an exposure the company has not yet quantified, per GuruFocus and TIKR.
Medicare Advantage membership has fallen by 935,000 since year-end 2025 (24/7 Wall St.), and operating margin fell to 4.8% in 2025 from 8.1% in 2024 (TIKR).
Management has promised to give its 2027 outlook before year-end, according to TIKR.
This article is for education and information only and is not investment advice. Investment decisions are yours to make after your own research.
Gotrade is the trading name of Gotrade Securities Inc., which is registered with and supervised by the Labuan Financial Services Authority (LFSA). This content is for educational purposes only and does not constitute financial advice. Always do your own research (DYOR) before investing.
M. Alfathan Rahman is a content writer with over 3 years of experience developing digital content strategies across various industries, including fintech. He has experience producing content for tax-related websites and financial education platforms. His focus areas include data research, and crafting financial articles that are informative, accurate, and accessible to investors of all experience levels.
Hendrie Saputra holds a Master of Business Administration (MBA) with a concentration in Business Risk & Finance, along with professional experience in finance, marketing, and project management. He is experienced in analyzing market data and developing research-driven business strategies.